VALIDITY OF THE PROSTATE SPECIFIC ANTIGEN TEST FOR PROSTATE CANCER SCREENING: FOLLOWUP STUDY WITH A BANK OF 21,000 SERA IN FINLAND-Reference-Cited by-同舟云学术

VALIDITY OF THE PROSTATE SPECIFIC ANTIGEN TEST FOR PROSTATE CANCER SCREENING: FOLLOWUP STUDY WITH A BANK OF 21,000 SERA IN FINLAND

Published:2001-12 Issue:6 Volume:166 Page:2189-2192
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HAKAMA MATTI¹,STENMAN ULF-HÅKAN¹,AROMAA ARPO¹,LEINONEN JARI¹,HAKULINEN TIMO¹,KNEKT PAUL¹

Affiliation:

1. From the Department of Public Health, Helsinki University, Tampere University School of Public Health, Finnish Cancer Registry, University Hospital of Helsinki, The National Public Health Institute, Helsinki, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. The results of prostate carcinoma screening in the U. S. as reflected in the surveillance, epidemiology, and end results program;Smart;Cancer,1997

2. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer;Stenman;Lancet,1994

3. Prospective observational study to assess value of prostatic specific antigen as screening test for prostate cancer;Parkes;BMJ,1995

4. Time-resolved immunofluorometric assay of prostate-specific antigen;Stenman;J Nucl Med Allied Sci, suppl.,1990

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrinology of Benign Prostatic Hyperplasia and Prostate Cancer;Endocrinology: Adult and Pediatric;2016

2. Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels;Urology;2014-06

3. Exploring medical student education initiatives: does the management of urologic conditions improve with a formal urology clinical clerkship?;Journal of Medicine and the Person;2011-10-29

4. Variable Prostate-specific Antigen Management Patterns by Nonurologist Providers at a Tertiary Care Medical Center;Urology;2011-08

5. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone;BJU International;2011-06-28